Danggui Shaoyaosan Regulates Nrf2/SLC7A11/GPX4 Signaling Pathway to Inhibit Ferroptosis in Rat Model of Non-alcoholic Fatty Liver Disease
|更新时间:2025-07-10
|
Danggui Shaoyaosan Regulates Nrf2/SLC7A11/GPX4 Signaling Pathway to Inhibit Ferroptosis in Rat Model of Non-alcoholic Fatty Liver Disease
“The latest research has found that Danggui Shaoyao San effectively treats non-alcoholic fatty liver disease by regulating the Nrf2/SLC7A11/GPX4 signaling pathway, inhibiting lipid peroxidation and ferroptosis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 16, Pages: 35-42(2025)
CHU Xinqiao,BIAO Yaning,GU Ying,et al.Danggui Shaoyaosan Regulates Nrf2/SLC7A11/GPX4 Signaling Pathway to Inhibit Ferroptosis in Rat Model of Non-alcoholic Fatty Liver Disease[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(16):35-42.
CHU Xinqiao,BIAO Yaning,GU Ying,et al.Danggui Shaoyaosan Regulates Nrf2/SLC7A11/GPX4 Signaling Pathway to Inhibit Ferroptosis in Rat Model of Non-alcoholic Fatty Liver Disease[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(16):35-42. DOI: 10.13422/j.cnki.syfjx.20242442.
Danggui Shaoyaosan Regulates Nrf2/SLC7A11/GPX4 Signaling Pathway to Inhibit Ferroptosis in Rat Model of Non-alcoholic Fatty Liver Disease
Mechanism of Betulinic Acid in Alleviating Non-alcoholic Fatty Liver Disease by Inhibiting Ferroptosis via p53/GPX4 Signaling Axis
Bioinformatics Reveals Mechanism of Schisandrin B in Inhibiting Ferroptosis to Ameliorate Methionine and Choline Deficiency-induced Fatty Liver Disease in Mice
Mechanisms and Strategy of Traditional Chinese Medicine in Treatment of Ischemic Stroke: A Review
Related Author
TANG Gaojun
HU Jie
LUO Li
ZHONG Zhu
LI Can
WU Huan
XU Wei
LI Yuanyuan
Related Institution
Clinical Medical College, Guizhou Medical University
The Affiliated Hospital of Guizhou Medical University